Opinion

Video

TKI Monotherapy Data in Non–Clear Cell RCC

Chandler H. Park, MD, highlights cabozantinib monotherapy data from the SWOG 1500 study in non–clear cell renal cell carcinoma.

Related Videos
Rohan Garje, MD
Manmeet Ahluwalia, MD, MBA, FASCO
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
David R. Spigel, MD, chief scientific officer, Sarah Cannon Research Institute
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Petros Grivas, MD, PhD; and Chandler Park, MD, MSc, FACP
Viktor Grünwald, MD, PhD
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center